Coccidioidomycosis in solid organ transplantation

Clinical Infectious Diseases

Volumn 33, Issue 9, 2001, Pages 1536-1544

  Blair, Janis E ^a   Logan, Joy L ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; KETOCONAZOLE; MICONAZOLE;

ADOLESCENT; ADULT; AGED; CHILD; CLINICAL FEATURE; COCCIDIOIDES IMMITIS; COCCIDIOIDOMYCOSIS; CONTROLLED STUDY; EMBASE; ENDEMIC DISEASE; FEMALE; FUNGUS CULTURE; HEART LUNG TRANSPLANTATION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDLINE; MORTALITY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RACE DIFFERENCE; RELAPSE; REVIEW; RISK FACTOR; SERODIAGNOSIS; SKIN TEST;

COCCIDIOIDOMYCOSIS; HUMANS; ORGAN TRANSPLANTATION; RISK FACTORS;

EID: 0035502918     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/323463     Document Type: Review

References (45)

1. Epidemiology of coccidioidomycosis
2. Coccidioidomycosis
3. Primary coccidioidomycosis
4. Disseminated coccidioidomycosis associated with immunosuppressive therapy following renal transplantation
5. Fungal pneumonia in transplant recipients
6. Markers of coccidioidomycosis before cardiac or renal transplantation and the risk of recurrent infection
7. Coccidioidomycosis in liver transplant patients
8. Coccidioidomycosis in renal replacement therapy
9. The efficacy of fluconazole in prevention of coccidioidomycosis following renal transplantation
10. Coccidioidomycosis and renal transplantation
11. Disseminated coccidioidomycosis. Unusual manifestations in a cardiac transplantation patient
12. Disseminated coccidioidomycosis detected by percutaneous liver biopsy in a liver transplant recipient
13. Coccidioidomycosis-induced thyroiditis and calcitriol-mediated hypercalcemia in a heart transplantation patient
14. Disseminated coccidioidomycosis in renal transplant patients
15. Intracranial infection in cardiac transplant recipients
16. A trial of vidarabine for cytomegalovirus infection in renal transplant patients
17. Infectious complications after small bowel transplantation in adults: An update
18. Musculoskeletal coccidioidomycosis. A review of 25 cases
19. Pathologic pulmonary alterations in long-term human heart-lung transplantation
20. Coccidioidomycosis in potentially compromised hosts: The effect of immunosuppressive therapy in dissemination
21. Coccidioidal choroiditis following renal transplantation
22. Coccidioidomycosis in recent renal or cardiac transplant recipients
23. Successful therapy of coccidioidomycosis of the knee with fluconazole
24. Simultaneous tuberculosis and coccidioidomycosis in end stage renal disease
25. Reactivation of Coccidioides infection
26. Withdrawal of immunosuppressive agents in the treatment of disseminated coccidioidomycosis
27. The compromised host and infection. II. Deep fungal infection
28. Coccidioidal meningitis: A follow-up report
29. Coccidioidomycosis in compromised hosts. Experience at Stanford University Hospital
30. Multi-organ failure caused by reactivated coccidioidomycosis without dissemination in a patient with renal transplantation
31. Disseminated coccidioidomycosis in a heart transplant recipient
32. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial
33. Coccidioidomycosis
34. Coccidioidomycosis and heart transplantation
35. Disseminated cocci: A ten year experience
36. Coccidioidomycosis in renal dialysis and transplant patients: Radiologic findings in 30 patients
37. Probable false positive coccidioidal serologic results in patients with cystic fibrosis
38. Coccidioidomycosis
39. Practice guidelines for the treatment of coccidioidomycosis
40. Emerging disease issues and fungal pathogens associated with HIV infection
41. Fluconazole therapy for coccidioidal meningitis
42. Interaction between cyclosporine and fluconazole in renal allograft recipients
43. Fluconazole therapy in transplant recipients receiving FK506
44. Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin
45. Treatment of systemic fungal infections with liposomal amphotericin B